Paul Rennie
Directeur Général chez PARADIGM BIOPHARMACEUTICALS LIMITED
Fortune : 4 M $ au 30/04/2024
Profil
Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., which was founded in 2014.
He currently holds the position of Executive Chairman & Managing Director at the company.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd.
as Non-Executive Chairman from 2021 to 2023, Stiefel Research Australia Pty Ltd.
as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd.
as Manager-Business Development, Mesoblast Ltd.
as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd.
as Manager-Sales & Marketing.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/02/2024 | 20 678 805 ( 5,90% ) | 4 M $ | 30/04/2024 |
Postes actifs de Paul Rennie
| Sociétés | Poste | Début |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Directeur Général | 22/11/2022 |
Anciens postes connus de Paul Rennie
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Directeur Général | 11/09/2023 |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Corporate Officer/Principal | - |
| MERCK KGAA | Sales & Marketing | - |
| Roche Diagnostics Australia Pty Ltd. | Sales & Marketing | - |
| MESOBLAST LIMITED | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| MERCK KGAA | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Health Technology |
| PARADIGM BIOPHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Bonlac Foods Ltd.
 Bonlac Foods Ltd. Food DistributorsDistribution Services Bonlac Foods Ltd. manufactures dairy products and ingredients for domestic and international customers. The firm products include fresh & UTH milk, milk powders, cheese, spreads, fruit juice, sport drinks, and yoghurts. The company is located in Melbourne, Australia. | Distribution Services |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
| Roche Diagnostics Australia Pty Ltd. |